Page last updated: 2024-11-02

pioglitazone and Alcohol Drinking

pioglitazone has been researched along with Alcohol Drinking in 8 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Alcohol Drinking: Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking.

Research Excerpts

ExcerptRelevanceReference
"We showed that activation of PPARγ receptors by pioglitazone (0, 10, and 30 mg/kg) and rosiglitazone (0, 10 and 30 mg/kg) given orally selectively reduced alcohol drinking."7.77Activation of nuclear PPARγ receptors by the antidiabetic agent pioglitazone suppresses alcohol drinking and relapse to alcohol seeking. ( Braconi, S; Cannella, N; Ciccocioppo, R; Cippitelli, A; Demopulos, G; Gaitanaris, G; Heilig, M; Kallupi, M; Massi, M; Ruggeri, B; Somaini, L; Stopponi, S, 2011)
"Pioglitazone is a selective peroxisome proliferator-activated receptor γ (PPARγ) agonist used for the treatment of insulin resistance and type 2 diabetes."5.39Activation of PPARγ by pioglitazone potentiates the effects of naltrexone on alcohol drinking and relapse in msP rats. ( Cannella, N; Ciccocioppo, R; Cippitelli, A; de Guglielmo, G; Demopulos, G; Gaitanaris, G; Heilig, M; Kallupi, M; Somaini, L; Stopponi, S; Ubaldi, M, 2013)
"Peroxisome proliferator-activated receptor γ (PPARγ) is an intracellular transcription factor whose signaling activation by the selective agonist pioglitazone reduces alcohol drinking and alcohol-seeking behavior in rats."4.02Activation of peroxisome proliferator-activated receptor γ reduces alcohol drinking and seeking by modulating multiple mesocorticolimbic regions in rats. ( Benvenuti, F; Borruto, AM; Ciccocioppo, R; Demopulos, G; Fotio, Y; Gaitanaris, G; Roberto, M, 2021)
" Recent studies support a role of PPARs in alcoholism and pioglitazone: a PPARγ agonist used for treatment of type 2 diabetes showed efficacy in reducing alcohol drinking, stress-induced relapse, and alcohol withdrawal syndrome in rats."3.96Further evidence for the involvement of the PPARγ system on alcohol intake and sensitivity in rodents. ( Ciccocioppo, R; Demopulos, G; Domi, A; Domi, E; Gaitanaris, G; Somaini, L; Ubaldi, M, 2020)
"We showed that activation of PPARγ receptors by pioglitazone (0, 10, and 30 mg/kg) and rosiglitazone (0, 10 and 30 mg/kg) given orally selectively reduced alcohol drinking."3.77Activation of nuclear PPARγ receptors by the antidiabetic agent pioglitazone suppresses alcohol drinking and relapse to alcohol seeking. ( Braconi, S; Cannella, N; Ciccocioppo, R; Cippitelli, A; Demopulos, G; Gaitanaris, G; Heilig, M; Kallupi, M; Massi, M; Ruggeri, B; Somaini, L; Stopponi, S, 2011)
" This study aimed to examine if pioglitazone, an antidiabetic reagent serving as a ligand of peroxisome proliferator-activated receptor gamma (PPAR gamma), could prevent alcoholic fatty liver."3.72Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met. ( Azuma, T; Inokuchi, S; Ishii, H; Kitamura, N; Nishida, J; Nishimura, T; Oka, A; Suematsu, M; Tamiya, G; Tomita, K, 2004)
"Pioglitazone is a selective peroxisome proliferator-activated receptor γ (PPARγ) agonist used for the treatment of insulin resistance and type 2 diabetes."1.39Activation of PPARγ by pioglitazone potentiates the effects of naltrexone on alcohol drinking and relapse in msP rats. ( Cannella, N; Ciccocioppo, R; Cippitelli, A; de Guglielmo, G; Demopulos, G; Gaitanaris, G; Heilig, M; Kallupi, M; Somaini, L; Stopponi, S; Ubaldi, M, 2013)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's4 (50.00)24.3611
2020's3 (37.50)2.80

Authors

AuthorsStudies
Fotio, Y1
Borruto, AM1
Benvenuti, F1
Demopulos, G4
Gaitanaris, G4
Roberto, M1
Ciccocioppo, R4
Domi, E1
Domi, A1
Ubaldi, M2
Somaini, L3
Dieperink, E1
Hauser, P1
Dockter, K1
Miranda, J1
Evenson, M1
Thuras, P1
Banini, BA1
Sanyal, AJ1
Stopponi, S2
de Guglielmo, G1
Cippitelli, A2
Cannella, N2
Kallupi, M2
Heilig, M2
Blednov, YA1
Benavidez, JM1
Black, M1
Ferguson, LB1
Schoenhard, GL1
Goate, AM1
Edenberg, HJ1
Wetherill, L1
Hesselbrock, V1
Foroud, T1
Harris, RA1
Braconi, S1
Ruggeri, B1
Massi, M1
Tomita, K1
Azuma, T1
Kitamura, N1
Nishida, J1
Tamiya, G1
Oka, A1
Inokuchi, S1
Nishimura, T1
Suematsu, M1
Ishii, H1

Other Studies

8 other studies available for pioglitazone and Alcohol Drinking

ArticleYear
Activation of peroxisome proliferator-activated receptor γ reduces alcohol drinking and seeking by modulating multiple mesocorticolimbic regions in rats.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2021, Volume: 46, Issue:2

    Topics: Alcohol Drinking; Animals; Nucleus Accumbens; Pioglitazone; PPAR gamma; Rats; Self Administration; V

2021
Further evidence for the involvement of the PPARγ system on alcohol intake and sensitivity in rodents.
    Psychopharmacology, 2020, Volume: 237, Issue:10

    Topics: Alcohol Drinking; Anilides; Animals; Dose-Response Relationship, Drug; Ethanol; Male; Mice; Mice, In

2020
Reduced alcohol use in patients prescribed pioglitazone.
    The American journal on addictions, 2021, Volume: 30, Issue:6

    Topics: Alcohol Drinking; Alcoholism; Humans; Pioglitazone; Veterans

2021
Treatment of NASH: What Helps Beyond Weight Loss?
    The American journal of gastroenterology, 2017, Volume: 112, Issue:6

    Topics: Alcohol Drinking; Comorbidity; Diagnosis, Differential; Diagnostic Imaging; Disease Progression; Hum

2017
Activation of PPARγ by pioglitazone potentiates the effects of naltrexone on alcohol drinking and relapse in msP rats.
    Alcoholism, clinical and experimental research, 2013, Volume: 37, Issue:8

    Topics: Alcohol Drinking; Animals; Cues; Drug Evaluation, Preclinical; Drug Therapy, Combination; Hypoglycem

2013
Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humans.
    Alcoholism, clinical and experimental research, 2015, Volume: 39, Issue:1

    Topics: Adult; Alcohol Drinking; Alcoholism; Alkanesulfonates; Animals; Bezafibrate; Brain; Female; Fenofibr

2015
Activation of nuclear PPARγ receptors by the antidiabetic agent pioglitazone suppresses alcohol drinking and relapse to alcohol seeking.
    Biological psychiatry, 2011, Apr-01, Volume: 69, Issue:7

    Topics: Adrenergic alpha-2 Receptor Antagonists; Alcohol Drinking; Alcohols; Analysis of Variance; Anilides;

2011
Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met.
    Gastroenterology, 2004, Volume: 126, Issue:3

    Topics: Alcohol Drinking; Animals; Apolipoproteins B; CCAAT-Enhancer-Binding Proteins; Cells, Cultured; DNA;

2004